Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom?

References

• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in2008: GLOBOCAN 2008.Int J Cancer 2010;127: 2893–917.
   Google Scholar
• Peters S, Adjei AA, Gridelli C, Reck M, Kerr K, Felip E, et al. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23(Suppl 7):vii56–64.
   PubMedGoogle Scholar
• Auperin A, Le Pechoux C, Rolland E, Curran WJ, Furuse K, Fournel P, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 2010;28:2181–90.
   PubMed Web of Science ®Google Scholar
• Haslett K, Pottgen C, Stuschke M, Faivre-Finn C. Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer. J Thorac Dis 2014;6:328–35.
   PubMed Web of Science ®Google Scholar
• Bradley J. A review of radiation dose escalation trials for non-small cell lung cancer within the Radiation Therapy Oncology Group. Semin Oncol 2005;32:S111–3.
   PubMed Web of Science ®Google Scholar
• Belderbos JS, Heemsbergen WD, De Jaeger K, Baas P, Lebesque JV. Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006; 66:126–34.
   PubMed Web of Science ®Google Scholar
• Cox JD. Are the results of RTOG 0617 mysterious? Int J Radiat Oncol Biol Phys 2012;82:1042–4.
   PubMed Web of Science ®Google Scholar
• Chi A, Nguyen NP, Welsh JS, Tse W, Monga M, Oduntan O, et al. Strategies of dose escalation in the treatment of locally advanced non-small cell lung cancer: Image guidance and beyond. Front Oncol 2014;4:156.
   PubMedGoogle Scholar
• van Baardwijk A, Reymen B, Wanders S, Borger J, Ollers M, Dingemans AM, et al. Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer. Eur J Cancer 2012;48:2339–46.
   PubMed Web of Science ®Google Scholar
• Guckenberger M, Richter A, Wilbert J, Flentje M, Partridge M. Adaptive radiotherapy for locally advanced non-small-cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control. Int J Radiat Oncol Biol Phys 2011;81:e275–82.
   PubMed Web of Science ®Google Scholar
• Bissonnette JP, Purdie TG, Higgins JA, Li W, Bezjak A. Cone-beam computed tomographic image guidance for lung cancer radiation therapy. Int J Radiat Oncol Biol Phys 2009;73:927–34.
   PubMed Web of Science ®Google Scholar
• Guckenberger M, Meyer J, Wilbert J, Richter A, Baier K, Mueller G, et al. Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors. Radiother Oncol 2007;83:57–64.
   PubMed Web of Science ®Google Scholar
• Kupelian PA, Ramsey C, Meeks SL, Willoughby TR, Forbes A, Wagner TH, et al. Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: Observations on tumor regression during treatment. Int J Radiat Oncol Biol Phys 2005;63:1024–8.
   PubMed Web of Science ®Google Scholar
• Woodford C, Yartsev S, Dar AR, Bauman G, Van Dyk J. Adaptive radiotherapy planning on decreasing gross tumor volumes as seen on megavoltage computed tomography images. Int J Radiat Oncol Biol Phys 2007;69:1316–22.
   PubMed Web of Science ®Google Scholar
• Knap MM, Hoffmann L, Nordsmark M, Vestergaard A. Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients. Acta Oncol 2010;49:1077–84.
   PubMed Web of Science ®Google Scholar
• Persoon LC, Egelmeer AG, Ollers MC, Nijsten SM, Troost EG, Verhaegen F. First clinical results of adaptive radiotherapy based on 3D portal dosimetry for lung cancer patients with atelectasis treated with volumetric-modulated arc therapy (VMAT). Acta Oncol 2013;52:1484–9.
   PubMed Web of Science ®Google Scholar
• Derycke S, De Gersem WR, Van Duyse BB, De Neve WC. Conformal radiotherapy of Stage III non-small cell lung cancer: A class solution involving non-coplanar intensity-modulated beams. Int J Radiat Oncol Biol Phys 1998;41: 771–7.
   PubMed Web of Science ®Google Scholar
• De Ruysscher D, Faivre-Finn C, Nestle U, Hurkmans CW, Le Pechoux C, Price A, et al. European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. J Clin Oncol 2010;28:5301–10.
   PubMed Web of Science ®Google Scholar
• Britton KR, Starkschall G, Tucker SL, Pan T, Nelson C, Chang JY, et al. Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography. Int J Radiat Oncol Biol Phys 2007;68: 1036–46.
   PubMed Web of Science ®Google Scholar
• Fox J, Ford E, Redmond K, Zhou J, Wong J, Song DY. Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2009;74:341–8.
   PubMed Web of Science ®Google Scholar
• Ramsey CR, Langen KM, Kupelian PA, Scaperoth DD, Meeks SL, Mahan SL, et al. A technique for adaptive image-guided helical tomotherapy for lung cancer. Int J Radiat Oncol Biol Phys 2006;64:1237–44.
   PubMed Web of Science ®Google Scholar
• Sonke JJ, Belderbos J. Adaptive radiotherapy for lung cancer. Semin Radiat Oncol 2010;20:94–106.
   PubMed Web of Science ®Google Scholar
• Seibert RM, Ramsey CR, Hines JW, Kupelian PA, Langen KM, Meeks SL, et al. A model for predicting lung cancer response to therapy. Int J Radiat Oncol Biol Phys 2007;67:601–9.
   PubMed Web of Science ®Google Scholar
• Chen CP, Weinberg VK, Jahan TM, Jablons DM, Yom SS. Implications of delayed initiation of radiotherapy: Accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer. J Thorac Oncol 2011; 6:1857–64.
   PubMed Web of Science ®Google Scholar
• Schmidt ML, Hoffmann L, Kandi M, Moller DS, Poulsen PR. Dosimetric impact of respiratory motion, interfraction baseline shifts, and anatomical changes in radiotherapy of non-small cell lung cancer. Acta Oncol 2013;52:1490–6.
   PubMed Web of Science ®Google Scholar
• Pantarotto JR, Piet AH, Vincent A, van Sornsen de Koste JR, Senan S. Motion analysis of 100 mediastinal lymph nodes: Potential pitfalls in treatment planning and adaptive strategies. Int J Radiat Oncol Biol Phys 2009;74:1092–9.
   PubMed Web of Science ®Google Scholar